THT 2024 Late-Breaking Clinical Science Announced
The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat
Source: newswise.com
📰 Nir Uriel News
Nir Uriel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nir Uriel. Real-time updates on events, politics, business and more.
THT 2024 Late-Breaking Clinical Science Announced
The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat
Source: newswise.com
'Big Step Forward' for Transcatheter Tricuspid Valve Replacement: TRISCEND II
TR was eliminated, safety looked good, and symptoms improved—all good news for hard-to-treat patients, say experts.
Source: tctmd.com
First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study
FIRE1 announced the start of the first U.S. clinical study of its remote heart failure monitoring system, designed to provide unique insights to the care team and alert to deteriorating patient conditions for the almost 10M Americans with HF
Source: dicardiology.com
Impulse Dynamics Announces First Implant for CCM-D Clinical Trial
World's First Device Combining CCM Therapy With an ICD in a Single Rechargeable Implant That Treats Both Heart Failure Symptoms and Sudden Cardiac DeathMARLTON, N.J., May 18, 2023 (GLOBE NEWSWIRE) -- Impulse
Source: finanznachrichten.de
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation
Data Highlights the Value of HeartCare and AlloSure Lung in Clinical Practice Leading Experts Present Latest Advancements in Heart and Lung Transplantation During CareDx Symposia ... | April 19, 2023
United States University Of Southern California Stanford University Hannah Mannem Nir Uriel Kiran Kaur Khush
Source: marketscreener.com
Collaboration will advance cardiac health through AI
A three-year, $15 million partnership between Cornell and NewYork-Presbyterian will employ artificial intelligence to help improve outcomes for people with cardiovascular disease.
Source: cornell.edu
New collaboration focuses on employing AI to help improve cardiovascular disease outcomes
Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is the focus of a three-year, $15 million collaboration among Cornell Tech, the Cornell Ann S. Bowers College of Computing and Information Science (Cornell Bowers CIS) and NewYork-Presbyterian – with physicians from its affiliated medical schools Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons (Columbia University VP&S).
Source: news-medical.net
Statin use associated with increased survival in severe COVID-19
E-Mail NEW YORK, NY (Feb. 26, 2021)--People who took statins to lower cholesterol were approximately 50% less likely to die if hospitalized for COVID-19, a study by physicians at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found. "Our study is one of the larger studies confirming this hypothesis and the data lay the groundwork for future randomized clinical trials that are needed to confirm the benefit of statins in COVID-19," says Aakriti Gupt...
Source: eurekalert.org